| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.57B | -2.9% |
| R&D Expense | $6.0M | +0.0% |
| SG&A Expense | $594.0M | +5.3% |
| Operating Income | $629.0M | -54.6% |
| Pre-tax Income | $687.0M | -50.6% |
| Income Tax | $207.0M | -43.9% |
| Net Income | $442.0M | -55.4% |
| EPS (Basic) | $1.05 | -55.1% |
| EPS (Diluted) | $1.04 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.13B | -0.5% |
| Short-term Investments | $2.02B | -29.3% |
| Accounts Receivable | $64.0M | -4.5% |
| Inventory | $417.0M | -3.5% |
| Current Assets | $3.94B | -16.5% |
| Total Assets | $11.83B | -10.6% |
| Current Liabilities | $2.17B | -9.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.41B | +24.9% |
| Capital Expenditures | $679.0M | -1.5% |
| Investing Cash Flow | -$522.0M | +38.9% |
| Financing Cash Flow | -$844.0M | -169.6% |
| Free Cash Flow | $734.0M | +66.1% |
| -54.4% |
| Total Liabilities |
| $4.67B |
| -12.0% |
| Stockholders' Equity | $6.48B | -8.1% |